Predictive factors for persistent use and compliance of immediate-release methylphenidate: A 36-month naturalistic study

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 6, 2009, Pages 673-681

  Atzori, Paola ^a   Usala, Tatiana ^a   Carucci, Sara ^a   Danjou, Fabrice ^a   Zuddas, Alessandro ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; CHILD; CLINICAL EVALUATION; COGNITION; COMORBIDITY; DECREASED APPETITE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RELEASE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHORIA; FAMILY INTERACTION; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; IRRITABILITY; LOGORRHEA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NATURALISTIC INQUIRY; OUTCOME ASSESSMENT; OVER FOCUSING; PATIENT COMPLIANCE; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SIDE EFFECT; TIC; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD, PRESCHOOL; DRUG TOLERANCE; FAMILY CHARACTERISTICS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; METHYLPHENIDATE; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 73449137689     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0146     Document Type: Article

References (49)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington (DC): American Psychiatric Association, 1994.
2. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Dopfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E: Longacting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 15:476-495, 2006.
3. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Leibson C.L, Jacobsen SJ: Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: Results from a populationbased study. J Dev Behav. Pediatr 27:1-10, 2006.
4. Barkley RA, McMurray MB, Edelbrock CS, Robbins K: Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics 86:184-192, 1990.
5. Barkley RA, Fischer M, Smallish L, Fletcher K: Young adult followup of hyperactive children: Antisocial activities and drug use. J Child Psychol Psychiatry 45:195-211, 2004.
6. Barkley RA, Fischer M, Smallish L, Fletcher K: Young adult outcome of hyperactive children: Adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 45:192-202, 2006.
7. Biederman J, Monuteaux MC, Mick E, Spencer T, Wilens TE, Silva JM, Snyder LE, Faraone SV: Young adult outcome of attention deficit hyperactivity disorder: A controlled 10-year follow-up study. Psychol Med 36:167-179, 2006.
8. Bokhari F, Mayes R, Scheffler RM: An analysis of the significant variation in psychostimulant use across the U.S. Pharmacoepidemiol Drug Safety 14:267-275, 2005.
9. Brown RT, Borden KA, Clingerman SR: Adherence to methylphenidate therapy in a pediatric population: A preliminary investigation. Psychopharmacol Bull 21:28-36, 1985.
10. Brownell MD, Mayer T, Chateau D: The incidence of methylphenidate use by Canadian children: What is the impact of socioeconomic status and urban or rural residence? Can J Psychiatry 51:847-854, 2006.
11. Buitelaar JK, Michelson D, Danckaerts M, Gillberg C, Spencer TJ, Zuddas A, Faries DE, Zhang S, Biederman J: A randomized, double-blind study of continuation treatment for attention-deficit/ hyperactivity disorder after 1 year. Biol Psychiatry 61:694-699, 2007.
12. Charach A, Gajaria A: Improving psychostimulant adherence in children with ADHD. Expert Rev Neurother 8:1563-1571, 2008.
13. Charach A, Ickowicz A, Schachar R: Stimulant treatment over five years: Adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry 43:559-567, 2004.
14. Charach A, Volpe, T, Boydell KM, Gearing RE: A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv Rev Psychiatry 16:126-135, 2008.
15. Conners CK: Conners Rating Scales, Revised. Toronto, Canada: Multi-Health Systems, 1997.
16. Corkum P, Rimer P, Schachar R: Parental knowledge of attentiondeficit hyperactivity disorder and opinions of treatment options: Impact on enrollment and adherence to a 12-month treatment trial. Can J Psychiatry 44:1043-1048, 1999.
17. Cornoldi C, Colpo G: Prove di lettura MT per la scuola elementare (Test of reading MT for primary school). Firenze, Italy: 1998.
18. Faraone SV, Biederman J, Mick E: The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of followup studies. Psychol Med 36:159-165, 2006.
19. Faraone SV, Biederman J, Zimmerman B: An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD. J Atten Disord 11:157-166, 2007.
20. Firestone P: Factors associated with children's adherence to stimulant medication. Am J Orthopsychiatry 52:447-457,. 1982
21. Gau SS, Shen HY, Chou MC, Tang CS, Chiu YN, Gau CS: Determinants of adherence to methylphenidate and the impact of poor adherence on maternal and family measures. J Child Adolesc Psychopharmacol 16:286-297, 2006.
22. Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B, Eidevall-Wallin L, Gustafsson P, Kopp S: Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebocontrolled trial. Arch Gen Psychiatry 54:857-864, 1997.
23. Guy W: Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology. Rockville (Maryland): National Institute of Mental Health, 1976.
24. Ibrahim E Sr: Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder. Hum Psychopharmacol 17:225-231, 2002.
25. Ickowicz A, Schachar RJ, Sugarman R, Chen SX, Millette C, Cook L: The parent interview for child symptoms: A situation-specific clinical research interview for attention-deficit hyperactivity and related disorders. Can J Psychiatry 51:325-328, 2006.
26. Jensen PS, Arnold LE, Swanson JM, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Hinshaw SP, Pelham WE, Wells KC, Conners CK, Elliott GR, Epstein JN, Hoza B, March JS, Molina BS, Newcorn JH, Severe JB, Wigal T, Gibbons RD, Hur K: 3-Year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 46:989-1002, 2007.
27. Johnson S: Chronic diseases of childhood: Assessing compliance with complex medical regimes. In Developmental Aspects of Health Compliance Behavior. E.L.J.S.Y.S. Krasnegor NA, ed. Hillsdale (New Jersey): Lawrence Erlbaum Assoc, 1993, pp 177-179.
28. Kolko DJ, Bukstein OG, Barron J: Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: Main and incremental effects across settings. J Am Acad Child Adolesc Psychiatry 38:578-586, 1999.
29. Kovacs M: Children's Depression Inventory Manual. North Tonawanda (New York): Multi-Health Systems, 1992.
30. March JS, Parker JD, Sullivan K, Stallings P, Conners CK: The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. J Am Acad Child Adolesc Psychiatry 36:554-565, 1997.
31. Marcus SC, Wan GJ, Kemner JE, Olfson M: Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 159:572-578, 2005.
32. McBride MC: An individual double-blind crossover trial for assessing methylphenidate response in children with attention deficit disorder. J Pediatr 113:137-145, 1988.
33. Miller AR, Lalonde CE, McGrail KM: Children's persistence with methylphenidate therapy: A population-based study. Can J Psychiatry 49:761-768, 2004.
34. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 56:1073-1086, 1999.
35. Panei P, Arcieri R, Vella S, Bonati M, Martini N, Zuddas A: Italian attention-deficit/hyperactivity disorder registry. Pediatrics 114:514, 2004.
36. Pelham WE Jr, Waschbusch DA, Hoza B, Pillow DR, Gnagy EM: Effects of methylphenidate and expectancy on performance, selfevaluations, persistence, and attributions on a social task in boys with ADHD. Exp Clin Psychopharmacol 9:425-437, 2001. (Pubitemid 33117494)
37. Pliszka S: Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46:894-921, 2007.
38. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164:942-948, 2007.
39. Schachar RJ, Tannock R, Cunningham C, Corkum PV: Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J AmAcad Child Adolesc Psychiatry 36:754-763, 1997.
40. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT: Psychotropic medication in children: A study from the Netherlands. Pediatrics 108:E25, 2001.
41. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A children's global assessment scale (CGAS). Arch Gen Psychiatry 40:1228-1231, 1983.
42. Sleator EK, Ullmann RK, von NA: How do hyperactive children feel about taking stimulants and will they tell the doctor? Clin Pediatr (Phila) 21:474-479, 1982.
43. Swanson J: Compliance with stimulants for attention-deficit/ hyperactivity disorder: Issues and approaches for improvement. CNS Drugs 17:117-131, 2003.
44. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder-first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):17-30, 2004.
45. Thiruchelvam D, Charach A , Schachar RJ: Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 40:922-928, 2001.
46. van Lier PA, van der EJ, Koot HM, Verhulst FC: Which better predicts conduct problems? The relationship of trajectories of conduct problems with ODD and ADHD symptoms from childhood into adolescence. J Child Psychol Psychiatry 48:601-608, 2007.
47. Wechsler D: Wechsler Intelligence Scale for Children, Revised Edition (WISC-R). New York: Psychological Corporation, 1974.
48. Weiss G, Minde K, Werry JS, Douglas V, Nemeth E: Studies on the hyperactive child. 8. Five-year follow-up. Arch Gen Psychiatry 24:409-414, 1971.
49. Zuddas A, Marzocchi GM, Oosterlaan J, Cavolina P, Ancilletta B, Sergeant J: Factor structure and cultural factors of disruptive behaviour disorders symptoms in Italian children. Eur Psychiatry 21:410-418, 2006.